EQT Agrees $12.1 Billion Purchase of Qiagen

Private equity firm EQT has agreed to acquire molecular testing company Qiagen for about $12.1 billion. The deal shows continued investor demand for businesses with specialist technology, strong customers and a clear role in healthcare. HPC can use this as a signal to source medical testing, laboratory and healthcare technology businesses for private equity and strategic buyers.